Literature DB >> 9620412

Randomly amplified polymorphic DNA genotyping of serogroup A meningococci yields results similar to those obtained by multilocus enzyme electrophoresis and reveals new genotypes.

A Bart1, I G Schuurman, M Achtman, D A Caugant, J Dankert, A van der Ende.   

Abstract

Randomly amplified polymorphic DNA (RAPD) genotyping was applied to one representative strain of each of the 84 electrophoretic types (ETs) of Neisseria meningitidis serogroup A previously defined by multilocus enzyme electrophoresis (MEE) (J.-F. Wang et al., Infect. Immun. 60:5267-5282, 1992). Twenty-seven additional isolates comprising six ETs were also tested. MEE and RAPD genotyping yielded similar dendrograms at the subgroup level. Similar results were obtained by both methods for 18 serogroup A meningococci isolated in The Netherlands between 1989 and 1993. Ten of these isolates defined a new subgroup, designated subgroup IX. One isolate belonged to the ET-5 complex, normally associated with serogroup B strains (D. A. Caugant et al., Proc. Natl. Acad. Sci. USA 83:4927-4931, 1986). By RAPD genotyping, meningococci can be linked to previously characterized genotypes by using a computerized database, and dendrograms based on cluster analyses can easily be generated. RAPD analysis offers advantages over MEE since intermediate numbers of isolates of serogroup A meningococci can quickly be assigned to known subgroups and new subgroups can be defined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620412      PMCID: PMC104912     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

Authors:  J F Wang; D A Caugant; X Li; X Hu; J T Poolman; B A Crowe; M Achtman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

2.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Authors:  J G Williams; A R Kubelik; K J Livak; J A Rafalski; S V Tingey
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

3.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Authors:  M C Maiden; J A Bygraves; E Feil; G Morelli; J E Russell; R Urwin; Q Zhang; J Zhou; K Zurth; D A Caugant; I M Feavers; M Achtman; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

4.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 5.  Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983.

Authors:  T Olyhoek; B A Crowe; M Achtman
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

6.  Use of arbitrarily primed polymerase chain reaction analysis to type disease and carrier strains of Neisseria meningitidis isolated during a university outbreak.

Authors:  J P Woods; D Kersulyte; R W Tolan; C M Berg; D E Berg
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

7.  The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation.

Authors:  J Suker; I M Feavers; M Achtman; G Morelli; J F Wang; M C Maiden
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

8.  Effect of concentration of MgCl2 on random-amplified DNA polymorphism.

Authors:  Y H Park; R J Kohel
Journal:  Biotechniques       Date:  1994-04       Impact factor: 1.993

9.  DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting.

Authors:  N Akopyanz; N O Bukanov; T U Westblom; S Kresovich; D E Berg
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

Review 10.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb
View more
  6 in total

1.  Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis.

Authors:  P Zhu; A van der Ende; D Falush; N Brieske; G Morelli; B Linz; T Popovic; I G Schuurman; R A Adegbola; K Zurth; S Gagneux; A E Platonov; J Y Riou; D A Caugant; P Nicolas; M Achtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

2.  Molecular and biological analysis of eight genetic islands that distinguish Neisseria meningitidis from the closely related pathogen Neisseria gonorrhoeae.

Authors:  S R Klee; X Nassif; B Kusecek; P Merker; J L Beretti; M Achtman; C R Tinsley
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Antigenic variation of the class I outer membrane protein in hyperendemic Neisseria meningitidis strains in the netherlands.

Authors:  A Bart; J Dankert; A van der Ende
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 4.  Application of molecular techniques to the study of hospital infection.

Authors:  Aparajita Singh; Richard V Goering; Shabbir Simjee; Steven L Foley; Marcus J Zervos
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

5.  Random amplified polymorphic DNA assay as a rapid tool in screening for Neisseria meningitidis serogroup C isolates of electrophoretic type 24.

Authors:  S Schmink; M W Reeves; B Plikaytis; T Popovic
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

6.  Molecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997.

Authors:  M Achtman; A van der Ende; P Zhu; I S Koroleva; B Kusecek; G Morelli; I G Schuurman; N Brieske; K Zurth; N N Kostyukova; A E Platonov
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.